Viewing Study NCT06185192



Ignite Creation Date: 2024-05-06 @ 7:55 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06185192
Status: RECRUITING
Last Update Posted: 2024-01-05
First Post: 2023-12-14

Brief Title: Efficacy of Viomes Precision Nutrition Program Towards Reducing HbA1c
Sponsor: Viome
Organization: Viome

Study Overview

Official Title: Efficacy of Viomes Precision Nutrition Program Towards Reducing HbA1c
Status: RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a randomized placebo-controlled trial that will test the efficacy of VPNP in reducing HbA1c Participant recruitment will occur through direct-to-participant enrollment No additional clinical sites will be used for recruitment
Detailed Description: This is a randomized placebo-controlled trial that will test the efficacy of VPNP in reducing HbA1c Participants with HbA1c levels between 65-89 inclusive will be recruited and randomized into either the placebo or intervention group The study duration for each participant will be approximately 90 days At the beginning of the 90 days the participant will complete online questionnaires a blood draw and a set of at-home sample collections for blood stool and saliva that will be sent back to Viome After the samples are analyzed the participant will receive dietary recommendations and either personalized supplements or placebo supplements The participant will follow the dietary recommendations and take the supplements for 90 days At the end of the 90 days the participant will once again complete online questionnaires a blood draw and a set of at-home sample collections for blood stool and saliva that will be sent back to Viome for analysis

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None